ARCHIVES

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

This article is from The Cancer Letter archive.

Vol. 37 No. 15 | April 15, 2011

Download PDF Visit The Full Archive

Related Articles

Amgen Commits $1.5M To CDC Foundation For Education Program

May 29, 2009

Youth Smoking Begins To Decline, NCI Says

April 5, 2002

New GAO Report Critical Of federal Effort Against Environmental Carcinogenesis

June 25, 1976

Freement Lists Steps For Dealing With Disadvantaged

September 7, 1990

In Brief: Pittsburgh Joins List Of Comprehensive Center Prospect; FDA Schedules Meeting On Cancer Drugs

July 11, 1975

Report Urges Heated Chemo To Optimize Patient Survival

November 24, 2006